Epidermolysis Bullosa Latest Advances

Bullous Diseases in the Perioperative Setting: Anesthetic Considerations.

Journal: Cureus

Published: January 13, 2026

Oral Rehabilitation with Dental Implants in Patients with Epidermolysis Bullosa: A Scoping Review.

Journal: The International journal of oral & maxillofacial implants

Published: January 12, 2026

Genetic analysis of a Chinese pedigree affected with Epidermolysis bullosa simplex due to a novel variant of KRT5 gene

Journal: Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics

Published: December 26, 2025

O04 Mission EB -mesenchymal intravenous stromal cell infusions in children with recessive dystrophic epidermolysis bullosa: a randomised, double-blinded, placebo controlled, crossover trial.

Journal: The British journal of dermatology

Published: December 18, 2025

A safer path to gene correction in junctional epidermolysis bullosa.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: December 15, 2025

Scarring Alopecia in Localized Dystrophic Epidermolysis Bullosa: A Case Report and a Scoping Review.

Journal: Cureus

Published: December 09, 2025

Efficacy of Aprepitant for Refractory Pruritus in Patients With Epidermolysis Bullosa and Atopic Dermatitis: A Retrospective Study.

Journal: Pediatrics

Published: November 30, 2025

Localized dominant dystrophic epidermolysis bullosa worsened by diabetes.

Journal: European journal of dermatology : EJD

Published: November 24, 2025

Co-occurrence of two monogenic diseases within a single family.

Journal: European journal of dermatology : EJD

Published: November 24, 2025

Nutritional support in the comprehensive management of cutaneous squamous cell carcinoma in congenital epidermolysis bullosa

Journal: Voprosy pitaniia

Published: November 20, 2025

From variant of unknown significance to actionable diagnosis: Stepwise interpretation of a novel KRT2 variant in superficial epidermolytic ichthyosis with excellent retinoid response.

Journal: JAAD international

Published: November 17, 2025

Multicentre phase II open study assessing the efficacy and safety of apremilast in children and adults with epidermolysis bullosa simplex generalised: study protocol for the EBULO study.

Journal: BMJ open

Published: November 12, 2025